CD69 and myalgic encephalomeyelitis/chronic fatigue syndrome: In addition, the validation of CD25 and CD69 expression in NK cells as potential markers in frozen cells was also clearly compromised by the inconsistent and highly variable levels of expression observed in the biobanked cells, which effectively ruled out their use in future ME/CFS studies with frozen samples.